NYKODE THERAPEUTICS ASA revenue breakdown overview

NYKODE THERAPEUTICS ASA revenue for the last year amounted to 132.42 M NOK, the most of which — 68.96 M NOK — came from its highest performing source at the moment, Novel Vaccines and Immunotherapies, the year earlier bringing 292.03 M NOK. The greatest contribution to the revenue figure was made by United States — last year it brought NYKODE THERAPEUTICS ASA 68.96 M NOK, and the year before that — 292.03 M NOK.